Overview
MBOT market data
Price History
MBOT price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.29 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.03 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -3,496.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.60 – $4.67 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $114.2M · P/B 1.73 · P/S 1,087.43.
Company News
Microbot Medical shares are trading lower after B. Riley Securities lowered its price target on the stock from $5 to $4.Benzinga · Aug 14, 2026, 7:13 PM
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4Benzinga · Aug 14, 2026, 4:06 PM
Microbot Medical shares are trading lower after the company reported worse-than-expected Q2 sales results.Benzinga · Aug 11, 2026, 3:17 PM
8-K filing — Microbot Medical Inc. (MBOT)SEC EDGAR · Aug 11, 2026, 2:28 PM
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K EstimateBenzinga · Aug 11, 2026, 1:24 PM
Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2Benzinga · Jul 7, 2026, 12:40 PM
Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely Operated Endovascular Robotic SystemBenzinga · Jun 30, 2026, 12:35 PM
Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare SystemsBenzinga · Jun 16, 2026, 12:45 PM
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4Benzinga · Jun 3, 2026, 5:55 PM
Microbot Medical Secures First Contract In North Carolina For Liberty Endovascular Robotic System; Terms Not DisclosedBenzinga · Jun 2, 2026, 12:41 PM